According to Genmab's latest financial reports the company's current EPS (TTM) is HK$7.81. In 2022 the company made an earnings per share (EPS) of HK$9.03 an increase over its 2021 EPS that were of HK$5.57.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$7.89 | -12.67% |
2022 | HK$9.03 | 62.07% |
2021 | HK$5.57 | -35.78% |
2020 | HK$8.68 | 119.14% |
2019 | HK$3.96 | 36.35% |
2018 | HK$2.91 | 29.83% |
2017 | HK$2.24 | 0.92% |
2016 | HK$2.22 | 47.69% |
2015 | HK$1.50 | 109.32% |
2014 | HK$0.72 | 134.03% |
2013 | HK$0.31 | -121.08% |
2012 | -HK$1.45 | -23.69% |
2011 | -HK$1.91 | 94.77% |
2010 | -HK$0.98 | -70.48% |
2009 | -HK$3.31 |